Aclaris Therapeutics Eulerpool Novinky

Aclaris Therapeutics Novinky o akciích

Aclaris Therapeutics je sledován mnoha novináři a investory po celém světě. Nejaktuálnější Aclaris Therapeutics zprávy shromažďujeme zde.

• 2. června ·

  Yahoo
  Aclaris Therapeutics Initiates Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis
• 10. května ·

  Yahoo
  Aclaris Therapeutics First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
• 29. dubna ·

  Yahoo
  Aclaris Therapeutics Appoints Jesse Hall, M.D. as Chief Medical Officer
• 25. dubna ·

  Yahoo
  Strong week for Aclaris Therapeutics (NASDAQ:ACRS) shareholders doesn't alleviate pain of three-year loss
• 22. dubna ·

  Yahoo
  Aclaris Therapeutics Secures U.S. Food and Drug Administration IND Clearance for ATI-052, Enabling Advancement of its Novel Bispecific Anti-TSLP/IL-4R Investigational Antibody
• 4. března ·

  Yahoo
  Aclaris Therapeutics to Participate in Two March Healthcare Conferences
• 4. března ·

  Yahoo
  Aclaris Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
• 27. února ·

  Yahoo
  Aclaris: Q4 Earnings Snapshot
• 11. února ·

  SeekingAlpha
  Aclaris Therapeutics: History Of Failures, And Recent Acquisition Of A 'Blockbuster Potential' Molecule
• 6. ledna ·

  Yahoo
  Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)